Music |
Video |
Movies |
Chart |
Show |
Faron Pharma to expand its Clevegen trial to focus on Colorectal cancer (Proactive Investors) View | |
Faron Pharma set to expand Clevegen cancer trial as data continues to impress (Proactive Investors) View | |
Nivolumab plus low-dose ipilimumab promising for treatment-naïve MSI-high mCRC | Heinz-Josef Lenz (Medicine Matters oncology) View | |
() View | |
() View | |
() View | |
() View | |
() View | |
() View | |
() View |